JM Health rebrands as Veranova following sale to Altaris Capital Partners

See more

Featured insights from our experts

Read more

Ultra-pure synthetic cannabidiol (CBD)

We’re utilising our scientific and manufacturing expertise to develop and commercialise ultra-pure synthetic…

Read more

Early form screening strategies to accelerate candidate selection

Failure to select a successful candidate can be expensive in terms of both time and money.

Read more

Crystallization process development

Providing a first-choice opportunity—adopting crystallization development at an early stage.

Read more

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us